The Laerdal Million Lives Fund was created to pursue direct investments in innovative, enabling technologies and companies that can accelerate Laerdal’s global impact goal of saving over one million lives annually by 2030.
To achieve this goal, we are focused on supporting entrepreneurs who are meaningfully improving the coverage, quality and efficiency, safety and equity of healthcare through (i) early interventions with high life-saving potential and lower costs to society, (ii) leveraging enabling technologies to improve the translation of better learning and education tools to alter patient outcomes, and (iii) creating collaborative initiatives that can provide for scale-up of implementation in geographies where impact is most needed.
We are targeting global impact across key clinical segments where mortality rates can be drastically improved.
Neonatal & Maternal Health
Front Line & Emergency Care
Medical Education, Training & Quality
We invest in companies with commercial-ready products and solutions capable of deploying and scaling impact via sustainable, stand-alone business models. We target initial investments of $1 – $5 million, with funds reserved for follow-on support.
Based in Stavanger and San Francisco, we invest in companies across all geographies. Regardless of where our portfolio companies are headquartered, we target companies taking a globally scalable approach to ensuring their technologies can access providers and patients in the greatest need.